| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-06 |